Tumor Progression
Cancer Prevention
Mutagenicity and Carcinogenicity
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 25, 2026

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 29, 2010
Astrid Lièvre1, Pierre Laurent-Puig
1U490 Laboratoire de toxicologie moléculaire, 45, rue des Saints-Péres, 75006 Paris.
Colorectal cancer arises from chromosomal or genetic instability, often linked to hereditary syndromes. Despite differing mechanisms, key signaling pathways like APC/beta-catenin are crucial for tumor development and patient management.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: